Author(s): Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S, Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S
Abstract Share this page
Abstract South Asia is home to one of the largest population of people with metabolic syndrome (MetS). The prevalence of MetS in South Asians varies according to region, extent of urbanization, lifestyle patterns, and socioeconomic/cultural factors. Recent data show that about one-third of the urban population in large cities in India has the MetS. All classical risk factors comprising the MetS are prevalent in Asian Indians residing in India. The higher risk in this ethnic population necessitated a lowering of the cut-off values of the risk factors to identify and intervene for the MetS to prevent diabetes and cardiovascular disease. Some pharmacological and nonpharmacological interventions are underway in MetS to assess the efficacy in preventing the diabetes and cardiovascular disease in this ethnic population.
This article was published in Indian J Endocrinol Metab
and referenced in Journal of Clinical & Experimental Cardiology